Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma

التفاصيل البيبلوغرافية
العنوان:	Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma
المؤلفون:	Mateos, María-Victoria, Chari, Ajai, Usmani, Saad Z., Goldschmidt, Hartmut, Weisel, Katja, Qi, Keqin, Londhe, Anil, Nair, Sandhya, Lin, Xiwu, Pei, Lixia, Ammann, Eric, Kobos, Rachel, Smit, Jennifer, Parekh, Trilok, Marshall, Alexander, Slavcev, Mary, Moreau, Philippe
المصدر:	In Clinical Lymphoma, Myeloma and Leukemia May 2023 23(5):385-393
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	21522650
DOI:	10.1016/j.clml.2023.02.006